Sandbox endocarditis: Difference between revisions
Jump to navigation
Jump to search
Line 3: | Line 3: | ||
*Antibiotic therapy for subacute disease, and in those who have received antibiotics recently can be delayed waiting the results of blood cultures, as this delay allows an additional blood cultures without the confounding effect of empiric treatment, which is very important in determining the causing pathogens.<ref>{{Cite book | last1 = Braunwald | first1 = Eugene | last2 = Bonow | first2 = Robert O. | title = Braunwald's heart disease : a textbook of cardiovascular medicin | date = 2012 | publisher = Saunders | location = Philadelphia | isbn = 978-1-4377-2708-1 | pages = }}</ref> | *Antibiotic therapy for subacute disease, and in those who have received antibiotics recently can be delayed waiting the results of blood cultures, as this delay allows an additional blood cultures without the confounding effect of empiric treatment, which is very important in determining the causing pathogens.<ref>{{Cite book | last1 = Braunwald | first1 = Eugene | last2 = Bonow | first2 = Robert O. | title = Braunwald's heart disease : a textbook of cardiovascular medicin | date = 2012 | publisher = Saunders | location = Philadelphia | isbn = 978-1-4377-2708-1 | pages = }}</ref> | ||
*On the other hand, the rapid progression of acute cases necessitate the start of empirical treatment antibiotic therapy once the blood cultures have been collected. | *On the other hand, the rapid progression of acute cases necessitate the start of empirical treatment antibiotic therapy once the blood cultures have been collected. | ||
Line 18: | Line 18: | ||
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Native valve}}'' | ! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Native valve}}'' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin sulbactam|Ampicillin-Sulbactam|Ampicillin-Sulbactam]] 12 g per 24 h IV in 4 equally divided doses x 4–6 weeks''''' | |||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin sulbactam]] | |||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | '''Plus''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | '''Plus''' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Gentamicin|Gentamicin sulfate]]'' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Gentamicin|Gentamicin sulfate]]'''''3 mg per kg per 24 h IV/IM in 3 equally divided doses x 4–6 weeks | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | '''Or''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | '''Or''' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Vancomycin]] | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Vancomycin]]'''''30 mg per kg per 24 h IV in 2 equally divided doses x 4–6 weeks | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | '''Plus''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | '''Plus''' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Gentamicin|Gentamicin sulfate]]'' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Gentamicin|Gentamicin sulfate]]'''''3 mg per kg per 24 h IV/IM in 3 equally divided doses x 4–6 weeks | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | '''Plus''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | '''Plus''' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ciprofloxacin]]'' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ciprofloxacin]]'''''1000 mg per 24 h PO or 800 mg per 24 h IV in 2 equally divided doses x 4–6 weeks | ||
|- | |- | ||
|} | |} | ||
Line 46: | Line 44: | ||
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Native valve pediatric dose}}'' | ! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Native valve pediatric dose}}'' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''[[Ampicillin sulbactam]]''' 300 mg per kg per 24 h IV in 4–6 equally divided doses''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''[[Ampicillin sulbactam|Ampicillin-Sulbactam]]''' 300 mg per kg per 24 h IV in 4–6 equally divided doses''' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''[[Gentamicin]]''' 3 mg per kg per 24 h IV/IM in 3 equally divided doses ''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''[[Gentamicin]]''' 3 mg per kg per 24 h IV/IM in 3 equally divided doses ''' | ||
Line 104: | Line 102: | ||
! Regimen || Dosage and Route || Duration(wk) | ! Regimen || Dosage and Route || Duration(wk) | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin sulbactam]]''''' ||'''12 g per 24 h IV in 4 equally divided doses'''||4–6 | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin sulbactam|Ampicillin-Sulbactam]]''''' ||'''12 g per 24 h IV in 4 equally divided doses'''||4–6 | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | '''Plus''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | '''Plus''' | ||
Line 183: | Line 181: | ||
| ||'''''<u>Native valve</u>'''''|| | | ||'''''<u>Native valve</u>'''''|| | ||
|- | |- | ||
| '''[[Ampicillin sulbactam]]'''||12 g per 24 h IV in 4 equally divided doses||4–6 | | '''[[Ampicillin sulbactam|Ampicillin-Sulbactam]]'''||12 g per 24 h IV in 4 equally divided doses||4–6 | ||
|- | |- | ||
| || '''''plus''''' || | | || '''''plus''''' || | ||
Line 201: | Line 199: | ||
| '''[[Ciprofloxacin]]'''||1000 mg per 24 h PO or 800 mg per 24 h IV in 2 equally divided doses||4–6 | | '''[[Ciprofloxacin]]'''||1000 mg per 24 h PO or 800 mg per 24 h IV in 2 equally divided doses||4–6 | ||
|- | |- | ||
| ||→'''Pediatric dose''': | | ||→'''Pediatric dose''': | ||
*'''[[Ampicillin sulbactam]]''' 300 mg per kg per 24 h IV in 4–6 equally divided doses | *'''[[Ampicillin sulbactam|Ampicillin-Sulbactam]]''' 300 mg per kg per 24 h IV in 4–6 equally divided doses | ||
*'''[[Gentamicin]]''' 3 mg per kg per 24 h IV/IM in 3 equally divided doses | *'''[[Gentamicin]]''' 3 mg per kg per 24 h IV/IM in 3 equally divided doses | ||
*'''[[Vancomycin]]''' 40 mg per kg per 24 h in 2 or 3 equally divided doses | *'''[[Vancomycin]]''' 40 mg per kg per 24 h in 2 or 3 equally divided doses | ||
*'''[[Ciprofloxacin]]''' 20–30 mg per kg per 24 h IV/PO in 2 equally divided doses | *'''[[Ciprofloxacin]]''' 20–30 mg per kg per 24 h IV/PO in 2 equally divided doses | ||
|- | |- | ||
| ||'''''<u>Prosthetic valve (early, ≤ 1y)</u>'''''|| | | ||'''''<u>Prosthetic valve (early, ≤ 1y)</u>'''''|| |
Revision as of 20:01, 14 January 2014
Empirical Antibiotic Therapy
- Antibiotic therapy for subacute disease, and in those who have received antibiotics recently can be delayed waiting the results of blood cultures, as this delay allows an additional blood cultures without the confounding effect of empiric treatment, which is very important in determining the causing pathogens.[1]
- On the other hand, the rapid progression of acute cases necessitate the start of empirical treatment antibiotic therapy once the blood cultures have been collected.
- Empirical therapy is needed for all likely pathogens, certain antibiotic agents, including aminoglycosides, is preferably avoided for its toxic effects.
- Clinical course of infection beside the epidemiological features should be considered upon selecting empirical treatment regimen.
- Consultation with an infectious disease specialist for the selection of one of the antibiotic regimens is recommended(See therapy for culture-negative endocarditis). [2]
|